Best Buy Co., Inc. — Fiscal 2022 Form 10-K
Business context and reporting period. Best Buy is an omnichannel technology retailer operating in the U.S. and Canada, with Domestic and International segments. Fiscal 2022 ended January 29, 2022, and comprised 52 weeks. The filing reports full-year results; it does not provide a clear standalone fiscal fourth-quarter financial summary in the supplied text.
Key financial results
| Metric | FY2022 | FY2021 |
|---|---|---|
| Revenue | $51.761 billion | $47.262 billion |
| Comparable sales growth | 10.4% | 9.7% |
| Gross profit / margin | $11.640 billion / 22.5% | $10.573 billion / 22.4% |
| Operating income / margin | $3.039 billion / 5.9% | $2.391 billion / 5.1% |
| Net earnings | $2.454 billion | $1.798 billion |
| Diluted EPS | $9.84 | $6.84 |
| Cash from operating activities | $3.252 billion | $4.927 billion |
Revenue rose 9.5% and diluted EPS increased 43.9%. Non-GAAP diluted EPS was $10.01 versus $7.91. The effective tax rate fell to 19.0% from 24.3%, mainly because of non-cash benefits from resolving discrete tax matters.
Segments and sales mix
- Domestic: Revenue increased 10.5% to $47.830 billion; comparable sales rose 11.0%; operating income was $2.795 billion, with a 5.8% margin. Online revenue was $16.430 billion, down 12.0% on a comparable basis year over year but up 115% versus FY2020.
- International: Revenue declined 1.0% to $3.931 billion, while comparable sales rose 3.3%; operating income increased to $244 million from $43 million. The revenue decline reflected the Mexico exit, partly offset by Canada growth and currency effects.
- Domestic comparable sales gains were strongest in appliances (+24.1%) and consumer electronics (+15.9%).
Cash, debt and liquidity
- Cash and cash equivalents were $2.936 billion, down from $5.494 billion. Current assets were $10.539 billion and current liabilities $10.674 billion; the current ratio fell to 1.0 from 1.2.
- Operating cash flow declined to $3.252 billion, primarily due to the timing and volume of inventory purchases and payments; inventory was $5.965 billion at year-end.
- Investing activities used $1.372 billion, including $468 million for acquisitions. Financing activities used $4.297 billion, largely reflecting $3.502 billion in share repurchases and $688 million in dividends.
- Long-term debt was $1.229 billion including finance lease obligations; outstanding note principal was $1.150 billion, due in 2028 and 2030. The $1.25 billion revolving credit facility was undrawn, and the company reported covenant compliance. Debt-to-earnings ratio was 0.5 versus 0.8.
Material changes, outlook and management commentary
- Management described FY2022 as a year of record revenue and earnings, citing sustained technology demand, sales growth and improved operating-income leverage. It also reported supply-chain and transportation challenges.
- Gross margin edged up overall, but Domestic gross margin declined, partly due to lower service margins and costs associated with the Best Buy Totaltech membership. Management said Totaltech pressures near-term profitability while aiming to increase customer lifetime value and sales.
- Best Buy acquired Current Health for $389 million and Yardbird for $79 million. The acquisitions support its health-at-home and outdoor-living strategies; purchase-price allocations were substantially complete but remained subject to change.
- All remaining Mexico stores closed in the first quarter of FY2022. Management expected approximately 20–30 Best Buy store closures annually through FY2025 and approximately 30 Outlet Centers by the end of FY2023.
- Management expected annual capital expenditures of at least $1 billion over the next three fiscal years. It announced approximately $1.5 billion of planned FY2023 share repurchases and increased the quarterly dividend 26% to $0.88 per share.
- FY2022 included a restructuring credit of $34 million, versus $254 million of restructuring charges in FY2021. No goodwill impairment was recorded. The filing identifies no material off-balance-sheet arrangements; it reports outstanding letters of credit of $74 million.
Risks and contingencies
Key risks include changes in consumer demand and discretionary spending; inflation, wage and transportation costs; supply-chain disruption and product shortages; intense price competition and pressure on margins; reliance on concentrated vendors (the five largest named suppliers represented about 56% of merchandise purchases); and labor availability and retention. The filing also highlights pandemic-related disruption, cybersecurity and privacy exposure, product safety, regulatory risks in healthcare, and potential geopolitical or trade disruptions. Legal proceedings are described generally; the supplied text does not provide a clear quantified estimate of their potential financial impact. Tax examinations and uncertain tax positions remain subject to resolution.
Important facts for investors to verify
- Whether elevated demand and FY2022 sales growth are sustainable as shopping patterns normalize, particularly given the year-over-year decline in online comparable sales.
- How Totaltech membership affects service margins, customer retention and lifetime value as the program scales.
- Whether supply, labor, freight and inflation pressures affect product availability, operating costs and gross margins.
- Cash generation and working-capital trends, given lower operating cash flow, reduced cash balances and a current ratio of 1.0.
- Capital allocation plans—including announced repurchases, dividends and higher capital spending—and their effect on liquidity and share count.
- Integration, growth assumptions and goodwill valuation for Best Buy Health; its $893 million goodwill balance is particularly dependent on forecast assumptions, although management reported no impairment.